Luisa Manning
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
-
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- CAR-T cell therapy research
Papers in
- Oncology 18
- Cancer Immunotherapy and Biomarkers 10
- PARP inhibition in cancer therapy 7
- CAR-T cell therapy research 5
-
- Cancer Research and Treatments 10
- Co-authors
- John Nemunaitis (24 shared papers)Laura Stanbery (12 shared papers)Phylicia Aaron (13 shared papers)Ernest Bognar (16 shared papers)Gladice Wallraven (13 shared papers)Staci Horvath (10 shared papers)Rodney P. Rocconi (13 shared papers)Neil Senzer (11 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Gynecologic Oncology (4 papers)European Respiratory Review (2 papers)Vaccines (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesSpainGermany
In The Last Decade
Luisa Manning
28 papers receiving 292 citations
Peers
Comparison fields: 5 of 42
- Reproductive Medicine 71
- Oncology 199
- Immunology 117
- Cancer Research 40
- Biotechnology 19
Countries citing papers authored by Luisa Manning
This map shows the geographic impact of Luisa Manning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisa Manning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisa Manning more than expected).
Fields of papers citing papers by Luisa Manning
This network shows the impact of papers produced by Luisa Manning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisa Manning. The network helps show where Luisa Manning may publish in the future.
Co-authors
The 25 scholars most cited alongside Luisa Manning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 47 | |
| 2 | 2021 | 26 | |
| 3 | 2021 | 20 | |
| 4 | 2020 | 19 | |
| 5 | 2022 | 15 | |
| 6 | 2023 | 15 | |
| 7 | 2022 | 15 | |
| 8 | 2021 | 14 | |
| 9 | 2017 | 14 | |
| 10 | 2020 | 14 | |
| 11 | Platelet-derived growth factor as an autocrine factor in murine malignant mesothelioma | 1993 | 12 |
| 12 | 2021 | 12 | |
| 13 | 2018 | 10 | |
| 14 | 2020 | 10 | |
| 15 | 2016 | 10 | |
| 16 | The role of platelet derived growth factor in the growth of human malignant mesothelioma | 1993 | 9 |
| 17 | 2022 | 8 | |
| 18 | 2021 | 6 | |
| 19 | 2017 | 4 | |
| 20 | 2021 | 4 |
About Luisa Manning
Luisa Manning is a scholar working on Oncology, Biotechnology, Immunology, Genetics and Reproductive Medicine, having authored 28 papers that have together received 299 indexed citations. Recurring topics across this work include Cancer Research and Treatments (10 papers), Cancer Immunotherapy and Biomarkers (10 papers), Immunotherapy and Immune Responses (9 papers), PARP inhibition in cancer therapy (7 papers), Ovarian cancer diagnosis and treatment (7 papers), Virus-based gene therapy research (6 papers), Cancer Genomics and Diagnostics (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Reproductive Medicine (71 citations), Oncology (199 citations), Immunology (117 citations), Cancer Research (40 citations) and Biotechnology (19 citations). Luisa Manning has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include John Nemunaitis, Laura Stanbery, Phylicia Aaron, Ernest Bognar, Gladice Wallraven, Staci Horvath, Rodney P. Rocconi, Neil Senzer, Minal Barve and Robert L. Coleman. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, European Respiratory Review, Vaccines and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.